Reversed ventilation-perfusion mismatch involving a pediatric patient in congestive heart failure

Journal of Nuclear Medicine

Volumn 38, Issue 11, 1997, Pages 1681-1683

  Zucker, Ivan ^a,b   Heyman, Sydney ^a   Ozdemir, Savas ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b C/o Radiology Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DOBUTAMINE; MILRINONE; TECHNETIUM 99M;

ADOLESCENT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CONGESTIVE HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HUMAN TISSUE; LUNG EDEMA; LUNG SCINTISCANNING; LUNG SQUAMOUS CELL CARCINOMA; LUNG TRANSPLANTATION; LUNG VENTILATION PERFUSION RATIO; MALE; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADOLESCENT; CARDIOTONIC AGENTS; DOBUTAMINE; HEART FAILURE, CONGESTIVE; HUMANS; LUNG; MALE; MILRINONE; PULMONARY CIRCULATION; PULMONARY VENTILATION; PYRIDONES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; VENTILATION-PERFUSION RATIO;

EID: 0030667354     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Carvalho B, Lavender JP. The incidence and etiology of the ventilation-perfusion reverse mismatch defect. Clin Nucl Med 1989;14:571-576.
2. Engeler CE, Kuni CC, Tashjian JH, Engeler CM, duCret RP. Regional alterations in lung ventilation in end-stage primary pulmonary hypertension. Am J Roentgenol 1995;164:831-835.
3. Slavin JD Jr, Mathews J, Spencer RP. Pulmonary ventilation-perfusion and reverse mismatches in an infant. Clin Nucl Med 1985;10:708-709.
4. Goodwin CA, Epstein DH. Lung perfusion scanning: the case of "reverse mismatch." Clin Nucl Med 1986;9:519-522.
5. Kuni CC, Ducret RP, Nakhleh RE, Boudreau RJ. Reverse mismatch between perfusion and aerosol ventilation lungs. Clin Nucl Med 1993;18:313-317.
6. Palmaz JC, Barnett CA, Reich SB, et al. Reverse ventilation-perfusion mismatch. Clin Nucl Med 1984;9:6-9.
7. Armas R. Large reverse mismatch associated with pulmonary embolism. Clin Nucl Med 1994;19:910-925.
8. Watanabe N, Hirano T, Inoue T, et al. Transient unilateral reverse ventilation-perfusion mismatch in a patient with lung cancer. Clin Nucl Med 1992;17:705-708.
9. Li DJ, Stewart I, Miles KA, Wraight EP. Scintigraphic appearances in patients with pulmonary infection and lung scintigrams of intermediate or low probability for pulmonary embolism. Clin Nucl Med 1994;19:1091-1093.
10. Enjeti S, O'Neill JT, Terry PB, et al. Effects of positive end expiratory pressure on shunt flow in atelectasis. Respir Physiol 1982;48:243.
11. Benumof JL, Wahrenbrock EA. Blunted hypoxic pulmonary vasoconstriction by increased lung vascular pressures. J Appl Physiol 1975;38:846-850.
12. Rouleau JL, de Champlain J, Klein M, et al. Activation of neurohumoral systems in post-infarction left ventricular dysfunction. J Am Coll Cardiol 1993;22:390-398.
13. Rouleau JL, Packer M, Lemuel M, et al. Prognostic value of neuro activation in patients with an acute myocardial infarction: effect of Captopril. J Am Coll Cardiol 1994;24:583-591.
14. Monrad ES, Baim DS, Smith HS, Lanque AS. Milrinone, dobutamine and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 1986;73(suppl III):168-174.
15. Eichhorn EJ, Konstam MA, Weiland DS, et al. Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987;60:1329-1333.